The present study confirmed several previously reported risk factors for BM: the female gender, age under 60 years, adenocarcinoma, N2 or N3 lymph node metastases, and mutation at EGFR 19 exon. The gene discussed is EGFR; the disease is metastatic malignant neoplasm in the lymph nodes.